Biotech

All Articles

Eli Lilly hops deeper right into AI with $409M Hereditary Leap deal

.Eli Lilly has actually vaulted in to an AI-enabled drug invention bargain, partnering with RNA expe...

After FDA denial and cutbacks, Lykos chief executive officer is actually leaving behind

.Lykos CEO and also owner Amy Emerson is actually walking out, with main operating officer Michael M...

Novartis fires up new phase of Voyager contract along with $15M capsid offer

.Novartis is opening a new frontier in its cooperation along with Voyager Therapeutics, paying $15 m...

Lilly posts extra good data on its own every week insulin prospect

.On the heels of an FDA denial for its chief rivalrous Novo Nordisk, Eli Lilly is actually making he...

IN 8bio standstills stage 2 trial, lays off fifty percent of labor force

.Just a couple of months after dosing the initial individual in a phase 2 test for recently diagnose...

Lilly, Haya ink $1B biobuck excessive weight pact to search black genome

.Eli Lilly's look for obesity aim ats has led it to the darker genome. The Big Pharma has actually a...

ArsenalBio raises $325M, rotates away from former lead resource

.Collection Biosciences is actually moving on up. The tissue treatment business has actually added $...

Lilly- backed effective weight loss biotech reports IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has submitted ...

Aelis' cannabis use medication flunks stage 2b, driving Indivior to rethink $100M choice

.Aelis Farma's hopes of protecting an easy, positive choice on a $one hundred million choice payment...

ProKidney stops stage 3 test certainly not required for tissue treatment approval

.ProKidney has actually quit one of a set of phase 3 trials for its cell therapy for renal illness a...